Metagenom Bio Inc: Protecting Intellectual Property Rights in China
This case deals with the planned market expansion of Metagenom Bio Inc. (MBI), a Canadian microbiome company that specializes in designing and structuring novel environmental monitoring and remediation technology and processes. The case revolves around the situation in 2019 facing Patrick Ang, the CEO of MBI, who has to take strategic decisions at a crucial point of MBI’s development of a potential entry to China while keeping confidential the details of the IP of MBI.
To provide students with a basic understanding of the business environment in China and to analyze the opportunities and challenges present to a foreign business entity. Students should be encouraged to analyze critically the viability of whether it is possible for a business entity such as MBI to keep its IP confidential while at the same time expanding its commercial operations into other jurisdictions.
|Company/Organization||Metagenom Bio Inc|
|Industry||Mining, Soil remediation|
|Major Discipline||International Business|
|Subject(s)||Intellectual property right protection, Sustainability, SWOT analysis, China business models, Risk analysis of foreign expansion, PESTEL analysis, Five-Force model, Soil remediation|
|Page count of the Case||15|
|Supplementary Materials||Case Presentation Slides|
|Last Revision Date||05.05.2020|